Dr Kayhan Ghatavi

MD, consultation-liaison psychiatrist and junior faculty member. Department of Psychiatry, Dalhousie University, Halifax, Canada.

Dr Ghatavi's special interests include psychosomatic medicine and medical education. He is currently working towards a Masters degree in medical education.


Contributions to CNSforum by Dr Kayhan Ghatavi:

22.11.2004

Maternal prenatal anxiety and corticotropin-releasing hormone associated with timing of delivery.

22.10.2004

Identifying women at-risk for depression in the immediate postpartum period

23.09.2004

Depression and 24-Hour Urinary Cortisol in Medical Outpatients with Coronary Heart Disease: The Heart and Soul Study

23.08.2004

Behavioural interventions in the rehabilitation of acute v. chronic non-organic (conversion/factitious) motor disorders

28.07.2004

A double-blind trial of risperidone and haloperidol for the treatment of delirium

18.06.2004

Cognitive-behavioural therapy for patients with multiple somatoform symptoms – a randomised controlled trial in tertiary care

24.05.2004

Cognitive Behavior Therapy for Hypochondriasis: A Randomized Controlled Trial.

20.04.2004

Relationship between atherosclerosis and late-life depression. The Rotterdam Study

24.03.2004

Increased Incidence of Diagnosed Depressive Illness in Hypogonadal Older Men

23.02.2004

The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes

28.01.2004

Gulf war illness – better, worse, or just the same? A Cohort Study

30.12.2003

Female gender is associated with impaired quality of life 1 year after coronary artery bypass surgery.

21.11.2003

Mood disturbance in community cancer support groups: The role of emotional suppression and fighting spirit.

28.10.2003

Accuracy of referring psychiatric diagnosis on a consultation-liaison service

25.09.2003

Implementing an effective intervention for problem drinkers on medical wards

25.08.2003

Alterations in Brain and Immune Function Produced by Mindfulness Meditation

28.07.2003

Effects of treating depression and low perceived social support on clinical events after myocardial infarction.

24.06.2003

Group therapy for somatization disorders in primary care: maintenance of treatment goals of short cognitive-behavioural treatment one-and-a-half-year follow-up

26.05.2003

A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients

30.04.2003

Six-month outcomes of hospital-based psychiatric substance use consultations

21.03.2003

Lifetime History of Depression and Carotid Atherosclerosis in Middle-aged Women

24.02.2003

Using chronic pain to predict depressive morbidity in the general population

29.01.2003

The clinical significance of major depression following mild traumatic brain injury

16.12.2002

Depression and cardiac morbidity 5 years after coronary artery bypass surgery

22.11.2002

Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample.

21.10.2002

Predicting the trajectory of will to live in terminally ill patients

25.09.2002

Axis I and II psychiatric disorders after traumatic brain injury: a 30-year follow-up study

19.08.2002

Attachment theory: a model for health care utilization and somatization

13.06.2002

A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder

13.06.2002

Existential or spirituality-based interventions may yield important clinical benefits

10.06.2002

A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder


Page Tools: